Investor profile
Pivotal bioVenture Partners has backed 2 European tech companies across 2 funding rounds between 2021 and 2025, joining rounds totalling €117M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Mosanna Therapeutics | Switzerland | 1 | €70M |
| Oculis | Switzerland | 1 | €47M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Mosanna Therapeutics | Series A | €70M | 2025-06 |
| Oculis | Series C | €47M | 2021-05 |
